Shervanthi Homer-Vanniasinkam
Director/Board Member at TISSUE REGENIX GROUP PLC
Net worth: 12 855 $ as of 2024-03-30
Profile
Shervanthi Homer-Vanniasinkam is an Independent Non-Executive Director at Tissue Regenix Group Plc since 2016.
She is also a Professor at the University of Warwick, University College London, and University Hospitals Coventry & Warwickshire NHS Trust.
She completed her undergraduate degree from the University of Mysore in 1981.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TISSUE REGENIX GROUP PLC
0.02% | 2023-12-30 | 16,282 ( 0.02% ) | 12 855 $ | 2024-03-30 |
Shervanthi Homer-Vanniasinkam active positions
| Companies | Position | Start |
|---|---|---|
| TISSUE REGENIX GROUP PLC | Director/Board Member | 2016-05-31 |
| University College London | Corporate Officer/Principal | - |
| University of Warwick | Corporate Officer/Principal | - |
University Hospitals Coventry & Warwickshire NHS Trust
 University Hospitals Coventry & Warwickshire NHS Trust Hospital/Nursing ManagementHealth Services University Hospitals Coventry & Warwickshire NHS Trust provides healthcare services. The non-profit company is based in Coventry, UK and has subsidiaries in the United Kingdom. The British company was founded in 1992. The CEO is Andrew Hardy. | Corporate Officer/Principal | - |
Training of Shervanthi Homer-Vanniasinkam
| University of Mysore | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TISSUE REGENIX GROUP PLC | Health Technology |
| Private companies | 1 |
|---|---|
University Hospitals Coventry & Warwickshire NHS Trust
University Hospitals Coventry & Warwickshire NHS Trust Hospital/Nursing ManagementHealth Services University Hospitals Coventry & Warwickshire NHS Trust provides healthcare services. The non-profit company is based in Coventry, UK and has subsidiaries in the United Kingdom. The British company was founded in 1992. The CEO is Andrew Hardy. | Health Services |
- Stock Market
- Insiders
- Shervanthi Homer-Vanniasinkam
